Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch From Tenofovir to Raltegravir for Low Bone Mineral Density in HIV
NCT00939874Phase 4Completed
- Sponsor
- St Vincent's Hospital
- Start
- Oct 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), osteopenia, osteoporosis, sponsored by St Vincent's Hospital. Started Oct 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)osteopeniaosteoporosis
Beyond the preview
Go deeper on NCT00939874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939874.